用于囊性纤维化的三联CFTR调节剂疗法 - Suppr

Suppr

超能文献

Triple CFTR Modulator Therapy for Cystic Fibrosis.

作者信息

Holguin Fernando

机构信息

From the Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora.

出版信息

N Engl J Med. 2018 Oct 25;379(17):1671-1672. doi: 10.1056/NEJMe1811996. Epub 2018 Oct 18.

DOI:10.1056/NEJMe1811996

PMID:30334694

Abstract

摘要

相似文献

Triple CFTR Modulator Therapy for Cystic Fibrosis.

N Engl J Med. 2018 Oct 25;379(17):1671-1672. doi: 10.1056/NEJMe1811996. Epub 2018 Oct 18.

CFTR mutations and cystic fibrosis.

Prescrire Int. 2013 Oct;22(142):232.

Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation.

N Engl J Med. 2020 Feb 13;382(7):684. doi: 10.1056/NEJMc1916747.

A little CFTR can change a lot: slowing cystic fibrosis progression.

Lancet Respir Med. 2017 Feb;5(2):86-87. doi: 10.1016/S2213-2600(16)30465-9. Epub 2016 Dec 21.

CFTR Modulator Therapy for Cystic Fibrosis.

N Engl J Med. 2017 Nov 23;377(21):2085-2088. doi: 10.1056/NEJMe1712335. Epub 2017 Nov 3.

Entering the era of highly effective CFTR modulator therapy.

Lancet. 2019 Nov 23;394(10212):1886-1888. doi: 10.1016/S0140-6736(19)32676-5. Epub 2019 Oct 31.

Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1065-75. doi: 10.1345/aph.1R076. Epub 2012 Jun 26.

Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.

Drugs Today (Barc). 2013 Apr;49(4):253-60. doi: 10.1358/dot.2013.49.4.1940984.

A combination therapy for cystic fibrosis.

Cell. 2015 Sep 24;163(1):17. doi: 10.1016/j.cell.2015.09.003.

F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.

Expert Opin Ther Pat. 2015;25(9):991-1002. doi: 10.1517/13543776.2015.1045878. Epub 2015 May 15.

引用本文的文献

Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.

PLoS One. 2023 Nov 29;18(11):e0295009. doi: 10.1371/journal.pone.0295009. eCollection 2023.

Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators.

Children (Basel). 2023 Jan 30;10(2):252. doi: 10.3390/children10020252.

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy.

Cureus. 2021 Jul 3;13(7):e16144. doi: 10.7759/cureus.16144. eCollection 2021 Jul.

Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor.

J Clin Med. 2021 May 7;10(9):1999. doi: 10.3390/jcm10091999.

Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

J Cyst Fibros. 2021 Sep;20(5):742-746. doi: 10.1016/j.jcf.2020.12.002. Epub 2020 Dec 31.

Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.

J Biol Chem. 2020 Dec 4;295(49):16529-16544. doi: 10.1074/jbc.RA120.014061. Epub 2020 Sep 15.

Genetic Variation Near chrXq22-q23 Is Linked to Emotional Functioning in Cystic Fibrosis.

Biol Res Nurs. 2020 Jul;22(3):319-325. doi: 10.1177/1099800420924125. Epub 2020 May 11.

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

Am J Rhinol Allergy. 2020 Jul;34(4):573-580. doi: 10.1177/1945892420912368. Epub 2020 Mar 13.

Exercise Physiology Across the Lifespan in Cystic Fibrosis.

Front Physiol. 2019 Nov 5;10:1382. doi: 10.3389/fphys.2019.01382. eCollection 2019.

Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis.

ACS Med Chem Lett. 2019 Oct 31;10(11):1543-1548. doi: 10.1021/acsmedchemlett.9b00377. eCollection 2019 Nov 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Triple CFTR Modulator Therapy for Cystic Fibrosis.

N Engl J Med. 2018 Oct 25;379(17):1671-1672. doi: 10.1056/NEJMe1811996. Epub 2018 Oct 18.

CFTR mutations and cystic fibrosis.

Prescrire Int. 2013 Oct;22(142):232.

Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation.

N Engl J Med. 2020 Feb 13;382(7):684. doi: 10.1056/NEJMc1916747.

A little CFTR can change a lot: slowing cystic fibrosis progression.

Lancet Respir Med. 2017 Feb;5(2):86-87. doi: 10.1016/S2213-2600(16)30465-9. Epub 2016 Dec 21.

CFTR Modulator Therapy for Cystic Fibrosis.

N Engl J Med. 2017 Nov 23;377(21):2085-2088. doi: 10.1056/NEJMe1712335. Epub 2017 Nov 3.

Entering the era of highly effective CFTR modulator therapy.

Lancet. 2019 Nov 23;394(10212):1886-1888. doi: 10.1016/S0140-6736(19)32676-5. Epub 2019 Oct 31.

Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1065-75. doi: 10.1345/aph.1R076. Epub 2012 Jun 26.

Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.

Drugs Today (Barc). 2013 Apr;49(4):253-60. doi: 10.1358/dot.2013.49.4.1940984.

A combination therapy for cystic fibrosis.

Cell. 2015 Sep 24;163(1):17. doi: 10.1016/j.cell.2015.09.003.

F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.

Expert Opin Ther Pat. 2015;25(9):991-1002. doi: 10.1517/13543776.2015.1045878. Epub 2015 May 15.

引用本文的文献

Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.

PLoS One. 2023 Nov 29;18(11):e0295009. doi: 10.1371/journal.pone.0295009. eCollection 2023.

Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators.

Children (Basel). 2023 Jan 30;10(2):252. doi: 10.3390/children10020252.

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy.

Cureus. 2021 Jul 3;13(7):e16144. doi: 10.7759/cureus.16144. eCollection 2021 Jul.

Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor.

J Clin Med. 2021 May 7;10(9):1999. doi: 10.3390/jcm10091999.

Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

J Cyst Fibros. 2021 Sep;20(5):742-746. doi: 10.1016/j.jcf.2020.12.002. Epub 2020 Dec 31.

Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.

J Biol Chem. 2020 Dec 4;295(49):16529-16544. doi: 10.1074/jbc.RA120.014061. Epub 2020 Sep 15.

Genetic Variation Near chrXq22-q23 Is Linked to Emotional Functioning in Cystic Fibrosis.

Biol Res Nurs. 2020 Jul;22(3):319-325. doi: 10.1177/1099800420924125. Epub 2020 May 11.

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

Am J Rhinol Allergy. 2020 Jul;34(4):573-580. doi: 10.1177/1945892420912368. Epub 2020 Mar 13.

Exercise Physiology Across the Lifespan in Cystic Fibrosis.

Front Physiol. 2019 Nov 5;10:1382. doi: 10.3389/fphys.2019.01382. eCollection 2019.

Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis.

ACS Med Chem Lett. 2019 Oct 31;10(11):1543-1548. doi: 10.1021/acsmedchemlett.9b00377. eCollection 2019 Nov 14.